Glenmark launches sitagliptin and its fixed-dose combinations, at affordable price for adults with type 2 diabetes in India
Jul 08, 2022
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs),...